| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Technology Officer
1 company
Sanders Dale serves as a Chief Technology Officer at HCAT. Across recent SEC filings that breaks down to 0 buys and 13 sells. Those positions are worth an estimated $326K at current prices.
The biggest single holding is HCAT (~$326K) as Chief Technology Officer. The recent filings there lean toward selling, a net 192,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2020 | HCAT Health Catalyst, Inc. | Chief Technology Officer | Sale+OE | 27,500 | $31.67 | $870,800.70 | -7.4% | |
| Aug 3, 2020 | HCAT Health Catalyst, Inc. | Chief Technology Officer | Sale+OE | 27,500 | $35.52 | $976,838.70 | -4.9% | |
| Jul 1, 2020 | HCAT Health Catalyst, Inc. | Chief Technology Officer | Sale+OE | 27,500 | $28.92 | $795,266.00 | -7.7% | |
| Jun 1, 2020 | HCAT Health Catalyst, Inc. | Chief Technology Officer | Sale+OE | 27,500 | $26.97 | $741,675.00 | -15.6% | |
| May 1, 2020 | HCAT Health Catalyst, Inc. | Chief Technology Officer | Sale+OE | 27,500 | $25.37 | $697,675.00 | -15.6% | |
| Apr 1, 2020 | HCAT Health Catalyst, Inc. | Chief Technology Officer | Sale+OE | 27,500 | $25.69 | $706,602.66 | -17.4% | |
| Mar 3, 2020 | HCAT Health Catalyst, Inc. | Chief Technology Officer | Sale+OE | 27,500 | $28.46 | $782,739.00 | -17.9% |